The use of selective serotonin reuptake inhibitors in children and adolescents with major: Depression

Journal of Child and Adolescent Psychiatric Nursing

Volumn 18, Issue 2, 2005, Pages 86-89

  Scahill, Lawrence ^a   Hamrin, Vanya ^a   Pachler, Mary Ellen ^b  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Medication safety; Search terms: Children and adolescents; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; CHILD; DEPRESSION; HUMAN; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CITALOPRAM; DEPRESSION; FLUOXETINE; HUMANS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 23944521386     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.2005.00015.x     Document Type: Article

References (17)

1. Anderson, G., Bennett, A., Weld, K., Pushkas, J., Ocame, D., & Higley, D. (2002) Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: Basal levels and effects of sertraline administration. Psychopharmacology, 161 (1), 95-99
2. Blier, P., & de Montigny, C. (1998). Possible serotonergic mechanisms underlying the antidepressant and antiobsessive-compulsive disorder responses. Biological Psychiatry, 44 (5), 313-23.
3. Chiu, S., & Leonard, H. (2003) Antidepressant 1: Selective serotonin reuptake inhibitors. In A. Martin, L. Scahill, D. S. Charney, & J.F. Leckman (Eds), Pediatric psychopharmacology: Principals and practice (pp. 274-294). New York, NY: Oxford University Press.
4. Emslie, G., Heiligenstein, J., Wagner, K., Hoog, S., Ernest, D., Brown, E., Nilsson, M., & Jacobson, J. (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41 (10), 1205-15.
5. Emslie, G., Rush, J., Weinberg, W., Kowatch, R., Hughs, C., Carmody, T., & Rintelman, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54 (11), 1031-1037.
6. Harris, G. (2004, November 6). FDA's Drug safety system will get outside review. The New York Times, p. A11.
7. Keller, M., Klein, R., Kutchner, S., Birmaher, B., Hagino, O., Koplewicz, H., Carlson, G., Clarke, G., Emslie, G., Feinberg, D., Geller, B., Kusumakar, V., Papatheodorou, G., Sack, W., Sweeney, M., Wagner, K., Weller, E., Winters, N., Oakes, R., & McCafferty, J. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40 (7), 762-772.
8. March, J., Beiderman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E., Cutler, N., Dominquez, R., Feruson, J., Muller, B., Riesenberg, R., Rosenthal, R., Sallee, F., Wagner, K., & Steiner, H. (1998). Sertraline in children and adolescents with obsessivecompulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association, 280 (20), 1752-1756.
9. Martin, A., Young, C., Leckman, J.F., Mukonoweshuro, C., Rosenheck, R., & Leslie, D. (2004). Age effects on antidepressant-induced manic conversion. Archives of Pediatrics and Adolescent Medicine, 158 (8): 773-780
10. Riddle, M.A., King, R.A., Hardin, M.T., Scahill, L., Ort, S.I., & Leckman, J.F. (1991). Behavioral side effects of fluoxetine. Journal of Child Adolescent Psychopharmacology, 3, 193-198.
11. Riddle, M., Reeve, E., Yaryura-Tobias, J., Yang, H., Claghorn, J., Gaffney, G., Greist, J., Holland, D., McConville, B., Pigott, T., & Walkup, J. (2001). Fluvoxamine for children and adolescents with obsessive compulsive disorder: A randomized controlled multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40 (2), 222-229.
12. Treatment for Adolescents with Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Journal of the American Medical Association, 292 (7), 807-820.
13. United States Food and Drug Administration. (2002). Clinical review; pediatric exclusivity. (Accessed December 1, 2004) [On-line]. Available: http://www.fda.gov/cder/foi/esum/2004/20031s037_paxil_Clincal_BPCA.
14. United States Food and Drug Administration. (2004a). Labeling change request letter for antidepressant medications. (Accessed November 30, 2004) [On-line]. Available: http://www.fda.gov/cder/drug/antidpressants/SSRIlabeling.
15. United States Food and Drug Adminstration. (2004b). Questions and answers on antidepressant use in children, adolescents and adults. (Accessed November 30, 2004) [On-line]. Available: http://www.fda.gov/cder/drug/antidepressants/Q&A_antidepressants.htm
16. Wagner, K., Robb, A.S., Findling, R.L., Jin, J., Gutierrez, M.M., & Heydorn, W.E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161 (6), 1079-1083
17. Wagner, K., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M., Childress, A., Donnelly, C., & Deas, D. (2003). Efficacy of sertraline in treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. Journal of the American Medical Association, 290 (8), 1033-1041.